Wellmind Health Ltd, the UK-founded provider of digital healthcare programmes, has expanded into the US market with the opening of the Boston office of its US subsidiary, Wellmind Health Inc.
Wellmind’s evidence-based digital courses are NHS-approved. The on-demand medication-free interventions aim to guide participants to improved, long-term outcomes.
Robert Adair, managing director, said: “The US market represents a tremendous opportunity for Wellmind Health Inc. We’re excited at the opportunity to leverage our close proximity to world-class hospitals and companies into forming meaningful partnerships within the US digital healthcare sector.”
Both its Be Mindful Mindfulness-Based Cognitive Therapy (MBCT) programme and Pathway through Pain Pain Management Programme (PMP) pathways are listed on the EMIS App Library and the NHS Apps Library, having passed NHS quality standards for clinical effectiveness, safety, security, usability and accessibility. They are provided to patients across the UK, from GP Surgeries and Pain Clinics to IAPT and Community Health Services. Along with NHS Trusts, Wellmind Health programmes also support health workers, teachers, police and ambulance services, and cancer nursing staff, as well as being available to individuals.
Richard Latham, CEO of Wellmind Health said: “Increasing attention is being paid to the efficacy and issues around the prescribing of opioid drugs for chronic pain and psychotropic medications for stress, depression and anxiety. Digital therapies such as our programmes are effective, economic and easily deployed and I hope our apps prove a valuable addition to the growing mix of medication-free alternatives for US doctors and their patients.”
